Semaglutide is contraindicated (should not be used) for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), those with a history of a serious allergic reaction to semaglutide, and those who are pregnant or breastfeeding. It is also not for use in people with type 1 diabetes.
Who should not take semaglutide
General injection-site reactions including erythema, pain, and rashes have been reported with all of the commercially available GLP-1 receptor agonists. Injection-site nodules have been seen with exenatide extended-release and semaglutide.
Amitriptyline may decrease the hypoglycemic activities of Semaglutide. Amitriptylinoxide may decrease the hypoglycemic activities of Semaglutide. The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Semaglutide.
Other medicines—Do not take other medicines during the time you are using semaglutide unless they have been discussed with your doctor. This especially includes nonprescription medicines such as aspirin, and medicines for appetite control, asthma, colds, cough, hay fever, or sinus problems.
Semaglutide therapy is contraindicated in patient with medullary thyroid carcinoma and hence multiple endocrine neoplasia type 2. Semaglutide therapy is also contraindicated in pregnant patients due to case study evidence of unfavorable fetal outcomes, which the manufacturer has considered in drug packaging.
Non-diabetic patients prescribed semaglutide have an increased likelihood of delayed gastric emptying and gallstones compared to those on other weight loss medications.
Supplements and herbs that may decrease your blood sugar and interact with Semaglutide include:
Semaglutide can start working within 1–3 days of your first dose, though noticeable effects like appetite changes and weight loss often take longer. People typically begin to see weight loss results within the first 4–12 weeks of treatment, including a reduction in appetite, fewer cravings, and less food noise.
Amitriptyline is from a group of medicines called tricyclic antidepressants. They're thought to work by increasing a chemical called serotonin in your brain. This can improve your mood. This can also change the way that your nerves receive pain signals so pain goes away.
Reported semaglutide overdose adverse events include gastrointestinal effects (e.g., nausea, vomiting, abdominal pain), fainting, headache, migraine, dehydration, acute pancreatitis and gallstones.
"Ozempic hands" is a slang term for the visible changes in hands due to rapid fat loss from GLP-1 drugs like Ozempic, making them look thinner, bonier, and more aged with prominent veins, tendons, and thinner skin, as subcutaneous fat diminishes and skin doesn't fully contract quickly. It's not a formal diagnosis but a common cosmetic effect of significant weight loss, similar to "Ozempic face".
Side effects that you should report to your care team as soon as possible: Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat. Change in vision. Dehydration—increased thirst, dry mouth, feeling faint or lightheaded, headache, dark yellow or brown urine.
“If you have a personal or family history of thyroid cancer (either medullary or neuroendocrine), semaglutide won't be prescribed,” Dr. Vedala says. Additionally, if you've had pancreatitis – a swelling of the lower part of the stomach—you should not use semaglutide.
Certain individuals may not be suitable candidates for GLP-1 therapy. People with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid these medications due to the potential risk of thyroid tumors.
To qualify for semaglutide for weight loss, you need to have a BMI of 30 or higher. Or a BMI of 27 or higher with at least one weight-related health condition, like high blood pressure or heart disease. But a healthcare provider can determine whether semaglutide is right for you.
Patients should notice a decrease in appetite fairly swiftly, if not immediately, after the first dosage. This often includes a reduction in cravings and an increased feeling of fullness following meals.
The short answer is that many of our patients lose weight in the first week of taking semaglutide. The first dose is small (0.25 mg). It is primarily used to gently introduce the medication to the body without risking developing severe side effects.
Incorporating a fitness program while using semaglutide or tirzepatide offers several benefits: Enhanced Weight Loss: Exercise complements the appetite suppression provided by these medications. Improved Muscle Tone: Prevents muscle loss while reducing fat.
How to Speed Up Weight Loss on Semaglutide
Why do people take vitamin B12 with compounded semaglutide? It's possible that some people may see a decrease in their vitamin B12 levels after starting semaglutide. In this case, a vitamin B12 supplement may be recommended to prevent or treat low levels.
High demand for weight loss medications has led to some drug shortages. Unable to get their prescription, some people have had to stop taking the medication abruptly or fear they may have to. If you are taking it for weight loss, there's no evidence yet that stopping semaglutide abruptly causes harm.
Those with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN2), pancreatitis, or gallbladder disease are not suitable candidates for Ozempic. In addition, this treatment is not intended for pregnant or breastfeeding women.
Basically, if you develop Ozempic feet, it means your rapid weight loss has sped up the natural process of fat pad atrophy in your feet. Some people are upset about this because it negatively impacts the appearance of their feet: the skin starts to sag, and the veins of the feet appear more prominent.